Concepedia

Author

Hisaaki Miyahara

Kyushu UniversityORCID

Also Known As

H MIYAHARA, H Miyahara, H. MIYAHARA, H. Miyahara, HISAAKI MIYAHARA, Hisa-aki Miyahara, Hisaaki MIYAHARA, Hisaaki Miyahara, Miyahara H

115

Publications

1.6K

Citations

21

H-Index

64

Concepts

All Affiliations

Kyushu UniversityNational Kyushu Medical CenterOno ClinicFukuoka HospitalOsaka Minami Medical Center
HM

About

Hisaaki Miyahara is an author at Kyushu University specializing in medicine, rheumatoid arthritis, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

17

474

2

Public Health

2

2

40

3

Allergy

2

2

34

4

Health Sciences

1

1

29

5

Biostatistics

1

1

13

Hisaaki Miyahara

×

42

Publications

1.5K

Citations

21

H-Index

YearCitations

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells

Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo,

Arthritis & Rheumatism

2011

224

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study

Norihiro Nishimoto, Koichi Amano, Yasuhiko Hirabayashi,

Modern Rheumatology

2013

119

LIMB ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH FK506

K Arai, Takao Hotokebuchi, Hisaaki Miyahara,

Transplantation

1989

90

Effect of IL-10 on collagen-induced arthritis in mice

Yosuke Tanaka, T Otsuka, Takao Hotokebuchi,

Inflammation Research

1996

86

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Kiyoshi Migita, Seiji Bito, Mashio Nakamura,

Arthritis Research & Therapy

2014

72

INDUCTION OF CHRONIC AUTOIMMUNE ARTHRITIS IN DBA/1 MICE BY ORAL ADMINISTRATION OF TYPE II COLLAGEN AND <i>ESCHERICHIA COLl LIPOPOLYSACCHARIDE</i>

Kuniaki Terato, X. J. Ye, Hisaaki Miyahara,

Lara D. Veeken

1996

52

Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese

Takahiko Horiuchi, Hiroshi Tsukamoto, Chika Morita,

Genes and Immunity

2000

49

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

Atsushi Ogata, Koichi Amano, Hiroaki Dobashi,

The Journal of Rheumatology

2015

47

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

Yasuharu Nakashima, Masakazu Kondo, Hiroshi Harada,

Modern Rheumatology

2010

46

Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study

Shigeki Momohara, Jun Hashi­moto, Hideki Tsuboi,

Modern Rheumatology

2012

46

Page 1